Advertisement

Xenogen Corporation Company Profile

02:50 EDT 26th May 2013 | BioPortfolio

Founded in 1998, Xenogen is the pioneer and leader in the field of biophotonic imaging. Xenogen's VivoVision Systems utilize biophotonic imaging and serve to expedite drug discovery and development, thereby minimizing up-front costs and significantly reducing the time to market for new therapies. Non-invasive in vivo biophotonic imaging illuminates biological processes taking place in a living mammal to track biological activity in real time, at the molecular level, and provides richer and higher quality in vivo data earlier in the drug discovery and development processes. Through VivoVision Solutions, Xenogen provides industry-leading genetic modification technologies that include in vivo biophotonic imaging and services to oversee the design and production of transgenic animal models. Xenogen offers a range of R&D program models, including oncology, angiogenesis, infectious disease, inflammation, immunology, and drug metabolism.
Xenogen’s VivoVision Biosciences has a long history of high quality design and production of genetic modifications for animal models through phenotypic characterization, pronuclear microinjection, and gene knockin/knockout mouse techniques and breeding services.

Location

860 Atlantic Avenue
Alameda
California
94501
United States of America

Contact

Phone: (510) 291-6100
Fax: (510) 291-6196
Email: businessdev@xenogen.com


News Articles [0 Results]

None

Drugs and Medications [0 Results]

None

PubMed Articles [ 2 Associated PubMed Articles listed on BioPortfolio]

Transferrin receptor targeting nanomedicine delivering wild-type p53 gene sensitizes pancreatic cancer to gemcitabine therapy.

To overcome gene therapy barriers such as low transfection efficiency and nonspecific delivery, liposomal nanoparticles targeted by a single-chain antibody fragment to the transferrin receptor (TfRscF...

Chlorotoxin labeled magnetic nanovectors for targeted gene delivery to glioma.

Glioma accounts for 80% of brain tumors and currently remains one of the most lethal forms of cancers. Gene therapy could potentially improve the dismal prognosis of patients with glioma, but this tre...

Clinical Trials [0 Results]

None

Companies [ 1 Associated Companies listed on BioPortfolio]

Xenogen Corporation

Founded in 1998, Xenogen is the pioneer and leader in the field of biophotonic imaging. Xenogen's VivoVision Systems utilize biophotonic imaging and serve to expedite drug discovery and development, t...

More Information about "Xenogen Corporation" on BioPortfolio

We have published hundreds of Xenogen Corporation news stories on BioPortfolio along with dozens of Xenogen Corporation Clinical Trials and PubMed Articles about Xenogen Corporation for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Xenogen Corporation Companies in our database. You can also find out about relevant Xenogen Corporation Drugs and Medications on this site too.

Search BioPortfolio:
Advertisement

Corporate Database Quicklinks



Searches Linking to this Company Record

Advertisement